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Correction: cyclooxygenase-2 inhibitors
TO THE EDITOR: The following points need to be corrected in our recent article 1 : (1) Lines 6 and 7 in the left column on page 981 should read, "…as the IC 50 for COX-1 divided by the IC 50 for COX-2." (2) The reference number cited on page 981 on the title line for Table 3 should be 12, not 11.
In addition, there may be some confusion related to the last column in Table 3 on page 981. This column, "Relative COX-2/COX-1 Selectivity (in vitro)," measures COX-2/COX-1 sensitivities, the inverse of the IC 50 ratios that would be expressed as COX-1/COX-2. For more information, see the original article from which these data were taken (reference 12 in the article, not reference 11). 
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